By Jeff Overley ( September 15, 2016, 5:55 PM EDT) -- A federal judge threatened "the entire balance" of the Biologics Price Competition and Innovation Act by allowing Hospira to withhold manufacturing information about a proposed biosimilar that may infringe patents, Amgen told the Federal Circuit in a brief unsealed Wednesday....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.